Breakthrough Bleeding Episodes at Minimum and Improvement in Quality of Life in a Child with Severe Hemophilia A with Inhibitors Treated with Emicizumab: A Case Report from Chile

Viviana Abarca-Villaseca; Verónica Soto-Arellano

doi:10.12659/AJCR.929598

22 April 2021: Articles

Breakthrough Bleeding Episodes at Minimum and Improvement in Quality of Life in a Child with Severe Hemophilia A with Inhibitors Treated with Emicizumab: A Case Report from Chile

Rare disease

Viviana Abarca-Villaseca ^A* , Verónica Soto-Arellano ^A

DOI: 10.12659/AJCR.929598

Am J Case Rep 2021; 22:e929598

Authors information Article notes Copyright and License information

Background Case Report Discussion Conclusions References:

View HTML version

Figure 1. Haemo-QoL standardized score by dimension. The 9 dimensions were sorted from highest to lowest, and the differences between before and after treatment were analyzed for each dimension. Haemo-QoL is a quality of life assessment instrument for children with hemophilia.

Back to the Article

Breakthrough Bleeding Episodes at Minimum and Improvement in Quality of Life in a Child with Severe Hemophilia A with Inhibitors Treated with Emicizumab: A Case Report from Chile

Your Privacy